Neurocrine Biosciences Inc. (NASDAQ: NBIX) Continues Work with a Deep Product Pipeline
In the world of bioscience, product development is all well and good but does little for potential investors until those products make their way through the approvals process. The closer the products get to approval, the closer an investor will be to potential profit. If an investor can find a company that is far enough along, but not too far along to boost its stock price out of range, he will be ready for a nice tidy profit when the product goes to market. Neurocrine Bioscience Inc., a bioscience company, works to develop and market a variety of neurological and…